Your browser is no longer supported. Please, upgrade your browser.
MRK Merck & Co., Inc. daily Stock Chart
Merck & Co., Inc.
IndexDJIA S&P500 P/E38.65 EPS (ttm)1.53 Insider Own0.05% Shs Outstand2.70B Perf Week-0.97%
Market Cap159.46B Forward P/E13.02 EPS next Y4.55 Insider Trans-13.03% Shs Float2.69B Perf Month-1.53%
Income4.18B PEG5.80 EPS next Q1.03 Inst Own75.80% Short Float0.76% Perf Quarter8.43%
Sales40.73B P/S3.92 EPS this Y29.20% Inst Trans-0.78% Short Ratio1.78 Perf Half Y9.37%
Book/sh12.49 P/B4.74 EPS next Y7.40% ROA1.80% Target Price68.40 Perf Year-8.33%
Cash/sh2.73 P/C21.71 EPS next 5Y6.66% ROE4.30% 52W Range52.83 - 66.41 Perf YTD5.15%
Dividend1.92 P/FCF1099.75 EPS past 5Y-1.90% ROI8.70% 52W High-10.90% Beta0.78
Dividend %3.24% Quick Ratio1.10 Sales past 5Y-3.20% Gross Margin68.60% 52W Low12.00% ATR1.15
Employees69000 Current Ratio1.40 Sales Q/Q6.40% Oper. Margin13.60% RSI (14)57.04 Volatility1.93% 1.95%
OptionableYes Debt/Eq0.70 EPS Q/Q-51.60% Profit Margin3.90% Rel Volume0.87 Prev Close58.45
ShortableYes LT Debt/Eq0.64 EarningsMay 01 BMO Payout326.40% Avg Volume11.44M Price59.17
Recom2.00 SMA201.00% SMA503.85% SMA2000.80% Volume9,900,427 Change1.23%
Apr-23-18Upgrade Goldman Neutral → Buy
Apr-17-18Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-05-18Upgrade Barclays Equal Weight → Overweight $62 → $64
Mar-12-18Upgrade Leerink Partners Mkt Perform → Outperform
Feb-14-18Reiterated Leerink Partners Mkt Perform $67 → $66
Feb-07-18Reiterated Morgan Stanley Equal-Weight $60 → $63
Jan-16-18Upgrade SunTrust Hold → Buy
Nov-28-17Resumed BofA/Merrill Buy $64
Nov-24-17Reiterated Deutsche Bank Hold $62 → $59
Oct-31-17Upgrade Jefferies Underperform → Hold
Oct-30-17Downgrade SunTrust Buy → Hold
Oct-30-17Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-30-17Downgrade Barclays Overweight → Equal Weight $72 → $62
Oct-18-17Upgrade Citigroup Neutral → Buy
Aug-09-17Upgrade HSBC Securities Reduce → Hold
Jul-31-17Reiterated UBS Buy $70 → $72
Jan-13-17Initiated Bryan Garnier Buy
Jan-12-17Upgrade Piper Jaffray Neutral → Overweight
Jan-12-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-12-17Upgrade Guggenheim Neutral → Buy
May-23-18 06:32PM  Trump Administration Ups Dose Of Shame As TV Drug Ad Policy Idea Moves Forward
05:56PM  Why Big Pharma is finally discovering the Bay Area American City Business Journals
04:43PM  Ebola patients slip out of Congo hospital as medics try to curb outbreak Reuters
03:24PM  7 S&P 500 Companies Doing Right for Employees InvestorPlace
11:57AM  Merck's cancer drug Keytruda notches another trial success Reuters
10:55AM  Why the world needs more than one Ebola vaccine Reuters
07:46AM  Three Ebola patients escape Congo quarantine, medics race to control outbreak Reuters
07:30AM  Mercks experimental and unlicensed Ebola vaccine is being used in latest outbreak MarketWatch
06:45AM  Mercks KEYTRUDA® (pembrolizumab) Significantly Improved Overall Survival and Progression-Free Survival as First-Line Treatment for Squamous Non-Small Cell Lung Cancer (NSCLC) in Pivotal Phase 3 KEYNOTE-407 Trial Business Wire
06:11AM  Three Ebola patients escape quarantine in Congo, two later die - MSF Reuters
May-22-18 02:21PM  Merck Announces Third-Quarter 2018 Dividend Business Wire
12:25AM  [$$] Ebola Vaccination Begins in Democratic Republic of Congo The Wall Street Journal
May-21-18 04:53PM  [$$] Ebola Vaccination Begins in Democratic Republic of Congo The Wall Street Journal
10:49AM  Factbox - From sterling crises to Brexit, the tests of Bank of England bosses Reuters
10:35AM  Congo begins giving experimental Ebola vaccine to medics Reuters
09:40AM  7 Blue-Chip Stocks That Arent Blue Chips at All InvestorPlace
May-20-18 07:42AM  Congo to begin Ebola vaccinations on Monday - health ministry Reuters
May-18-18 11:13AM  3 Dow Stocks to Buy With Dividends Yielding More Than 3% Motley Fool
06:00AM  Why J&J's Stock May Plunge 10% Investopedia
May-17-18 11:27AM  Investors Need to Adopt a Different Mindset for Big Pharma and Biotech Stocks InvestorPlace
10:03AM  Roche Tecentriq Combo Achieves Longer Overall Survival Rate Zacks
09:16AM  The Zacks Analyst Blog Highlights: Home Depot, Merck, Raytheon, Eaton and Sun Life Financial Zacks
May-16-18 06:10PM  Roche immunotherapy combination increases lung cancer survival-study Reuters
05:32PM  Merck's Keytruda boosts response in hard-to-treat lung cancer Reuters
05:05PM  New Data from Mercks Leading Immuno-Oncology Clinical Development Program in Over 25 Tumor Types to Be Presented at 2018 ASCO Annual Meeting Business Wire
02:37PM  MARKETS: Russell 2000 hits all-time high; Walmart earnings on deck; oil prices reverse; healthcare stocks in focus Yahoo Finance Video
10:54AM  Top Analyst Reports for Home Depot, Merck & Raytheon Zacks
May-15-18 01:31PM  Ebola Vaccine Headed to Congo to Help Contain Outbreak The Wall Street Journal
10:32AM  Merck KGaA (MKGAF) Q1 Earnings and Revenues Decline Y/Y Zacks
08:00AM  Free Stock Performance Review on Pfizer and Three More Drug Makers Stocks ACCESSWIRE
03:44AM  Merck KGaA Sees Profit Falling on Liquid Crystals Struggle Bloomberg Video
03:44AM  Merck KGaA Sees Profit Falling on Liquid Crystals Struggle Bloomberg
02:44AM  [$$] Merck KGaA's Sales Fall The Wall Street Journal
01:47AM  Merck KGaA Q1 earnings down on liquid crystals, currencies Reuters
01:21AM  Merck KGaA Q1 earnings down on liquid crystals, currencies Reuters
May-14-18 08:35PM  Merck & Co Inc. (NYSE:MRK) Is Trading At A 31% Discount Simply Wall St.
01:25PM  The Trump Plan To Reduce Prescription Drug Prices Will Have A Major Impact Forbes
09:40AM  What's in the Cards for Merck KGaA (MKGAF) in Q1 Earnings? Zacks
08:32AM  Dow Posts Longest Stretch of Gains in 6 Months: 4 Picks Zacks
May-13-18 06:31AM  Better Buy: Pfizer Inc. (PFE) vs. Merck (MRK) Motley Fool
May-12-18 09:28AM  Is Agenus Inc. (AGEN) a Buy? Motley Fool
May-11-18 05:02PM  Trump lets drug companies off the hook Yahoo Finance Video
10:17AM  US stock indexes edge higher in early trading; oil down Associated Press
10:13AM  Trump to announce ways to lower prescription drug costs Yahoo Finance Video
09:28AM  WHO hopes to use Ebola vaccine to stem outbreak in remote area of Congo Reuters
09:25AM  Merck vs. Pfizer: Which Stock Looks Better Post Q1 Earnings? Zacks
May-10-18 05:50PM  Big Peninsula biotech buyout means happy returns for Kleiner Perkins, other VCs American City Business Journals
May-09-18 04:27PM  Johnson & Johnson Stock Looks Attractive on the Big Dip InvestorPlace
07:30AM  Wired News Merck to Expand Use of Veeva Systems CRM in Latin America and Asia/Pacific ACCESSWIRE
May-08-18 03:59PM  Agenus' (AGEN) Q1 Loss Wider than Expected, Shares Down Zacks
06:45AM  LYNPARZA® (olaparib) Tablets Receive EU Approval for the Treatment of Platinum-Sensitive Relapsed Ovarian Cancer Business Wire
May-06-18 07:47AM  Merck & Co Inc. (NYSE:MRK): Time For A Financial Health Check Simply Wall St.
May-04-18 04:06PM  Pharma Stock Roundup: Mixed Q1 for MRK, PFE, FDA Nod for Kymriah's 2nd Indication Zacks
12:13PM  Is Trump Willing To Do What It Takes To Reduce High Prescription Drug Prices? Forbes
06:00AM  Eli Lilly Shares Seen Rising 18% as Profits Surge Investopedia
May-03-18 05:48PM  Biotech unicorn Moderna raises another $125M from partner Merck American City Business Journals
04:15PM  Moderna and Merck Expand mRNA Cancer Vaccines Collaboration Business Wire
06:45AM  Merck Provides Update on KEYNOTE-407 Trial Business Wire
05:31AM  Merck KGaA family says unreservedly behind the pharma unit Reuters
05:28AM  Merck KGaA CEO Happy With Portfolio, Celebrating 350th Year of Existence Bloomberg Video
05:27AM  Merck KGaA CEO Happy With Portfolio, Celebrating 350th Year of Existence Bloomberg
May-02-18 10:17AM  Company News for May 2, 2018 Zacks
09:36AM  Merck, Pfizer Deliver Checkup on Pharma Sector Bloomberg Video
08:04AM  Markets Await Confirmation of a June Rate Hike InvestorPlace
08:00AM  Why You Should Ditch Growth Stocks, Buy Value Investopedia
May-01-18 03:02PM  3 Numbers That Should Grab Your Attention in Merck's Q1 Earnings Motley Fool
02:52PM  Edited Transcript of MRK earnings conference call or presentation 1-May-18 12:00pm GMT Thomson Reuters StreetEvents
01:34PM  MARKETS: Stocks are selling off on the ISM miss, which also reveals problems in the factory sector Yahoo Finance Video
12:32PM  Merck dips, Under Armour slips, NutriSystem rips Yahoo Finance
12:26PM  Merck Company Inc. (MRK) Q1 2018 Earnings Conference Call Transcript Motley Fool
12:09PM  Merck posts strong first-quarter profit, but revenue light Associated Press
11:58AM  Keytruda sales power Merck to quarterly beat Reuters
11:11AM  Health-Care Earnings: Merck, Pfizer Disappoint With Q1 Revenue
10:58AM  Mercks Dangerous Keytruda Success Bloomberg
10:50AM  Merck (MRK) Beats on Q1 Earnings, Lags Sales, Raises Outlook Zacks
10:23AM  Apple Results, Fed Decision, Jobs Report In Focus; Merck, Pfizer Reports Mixed Benzinga
09:30AM  Don't Throw in the Towel on Merck After Earnings Selloff
08:52AM  Continue to Hold Longs in Merck, New Targets Seen
08:24AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
07:16AM  Keytruda powers Merck to first-quarter beat Reuters
07:14AM  Merck shares lift after Q1 profit beat, sales miss MarketWatch
07:12AM  Merck (MRK) Tops on Q1 Earnings, Misses Sales Zacks
06:45AM  Merck Announces First-Quarter 2018 Financial Results Business Wire
Apr-30-18 12:46PM  These big pharma names report earnings tomorrow CNBC Videos
11:58AM  Pharmaceutical Earnings: Pfizer And Merck Are Slated To Report Tuesday Morning Benzinga
10:11AM  Drug Stocks Q1 Earnings to Watch on May 1: PFE, MRK & More Zacks
08:20AM  Today's Research Reports on Trending Tickers: CRISPR Therapeutics and Merck & Co. ACCESSWIRE
07:07AM  Merck has submitted Keytruda combination for FDA approval MarketWatch
06:45AM  FDA Grants Priority Review to Mercks sBLA for KEYTRUDA® (pembrolizumab) in Combination with Pemetrexed (ALIMTA®) and Platinum Chemotherapy Based on Results from Phase 3 KEYNOTE-189 Trial as First-Line Treatment of Metastatic Nonsquamous NSCLC Business Wire
Apr-29-18 08:39AM  Economic Calendar - Top 5 Things to Watch This Week
Apr-27-18 04:52PM  What to Expect From Allergan, Aetna, Merck and Pfizer's Earnings Next Week
03:12PM  BMO Sees Balanced Risk-Reward In Bristol-Myers, Takes Neutral Position Benzinga
Apr-26-18 02:09PM  Bristol's Case for Opdivo Optimism Has Shaky Foundations Bloomberg
09:20AM  Merck vs. Pfizer: Which Stock is Better Before Q1 Earnings? Zacks
Apr-25-18 05:31PM  U.S. court upholds dismissal of $200 mln Merck verdict against Gilead Reuters
03:28PM  U.S. court upholds dismissal of $200 million Merck verdict against Gilead Reuters
08:59AM  Merck Gets Another Upgrade Thanks To Keytruda
08:03AM  What's in the Cards for Merck (MRK) This Earnings Season? Zacks
Apr-24-18 08:32AM  Get Paid While You Wait: 3 Top Dividend Stocks in Big Pharma Motley Fool
08:08AM  The Treasury Yield Is Trembling on the Edge of 3% InvestorPlace
Merck & Co., Inc. provides healthcare solutions worldwide. It operates in four segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The company offers therapeutic and preventive agents to treat cardiovascular diseases, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, and fertility diseases. It also provides neuromuscular blocking agents; anti-bacterial products; cholesterol modifying medicines; and vaginal contraceptive products. In addition, the company offers products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat brain tumors, and metastatic non-small-cell lung cancer; prevent diseases caused by human papillomavirus; and vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases. Further, it offers antibiotic and anti-inflammatory drugs to treat infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, horses, and swine; vaccines for poultry; parasiticide for sea lice in salmon; and antibiotics and vaccines for fishes. The company also provides companion animal products, such as ointments; diabetes mellitus treatment for dogs and cats; anthelmintic products; fluralaner products to treat fleas and ticks in dogs; and products for protection against bites from fleas, ticks, mosquitoes, and sandflies. It has collaborations with Pfizer Inc., AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., and IO Biotech. It serves drug wholesalers and retailers, hospitals, government agencies and entities, physicians, physician distributors, veterinarians, distributors, animal producers, and managed health care providers. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gerberding Julie L.EVP Strat Comm, Gl Pub PolicyMay 15Sale59.669,972594,96345,717May 16 12:33 PM
Watson AshleySVP Chief Ethics & Com OfficerMay 01Option Exercise0.0010,441012,783May 02 12:19 PM
Chattopadhyay SanatExe V-P & Pres. MMDMay 01Option Exercise0.004,009052,609May 02 12:18 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 01Option Exercise0.003,007022,205May 02 12:18 PM
GRADDICK WEIR MIRIAN MExe V-P, HRApr 16Sale58.0024,0001,392,00080,433Apr 17 05:56 PM
WEEKS WENDELL PDirectorFeb 09Option Exercise38.045,000190,2005,100Feb 09 04:48 PM
DeLuca Richard R.EVP&Pres, Merck Animal HealthFeb 09Option Exercise0.008,572045,780Feb 09 04:48 PM
WEEKS WENDELL PDirectorFeb 09Sale53.575,000267,833100Feb 09 04:48 PM
Schechter Adam HEVP & Pres-Global Human HealthJan 16Option Exercise36.5650,9941,864,34150,994Jan 16 05:13 PM
GRADDICK WEIR MIRIAN MExe V-P, HRJan 16Option Exercise44.3052,0002,303,600153,484Jan 16 05:12 PM
Holston Michael JEVP, General CounselJan 16Sale61.6312,500770,37549,092Jan 16 05:13 PM
Schechter Adam HEVP & Pres-Global Human HealthJan 16Sale61.6350,6083,118,97162,766Jan 16 05:13 PM
Schechter Adam HEVP & Pres-Global Human HealthJan 16Sale61.6350,9943,142,7600Jan 16 05:13 PM
GRADDICK WEIR MIRIAN MExe V-P, HRJan 16Sale61.6360,0003,697,80093,484Jan 16 05:12 PM
GRADDICK WEIR MIRIAN MExe V-P, HRJan 12Sale58.005,000290,000101,484Jan 16 05:12 PM
GLOCER THOMAS HDirectorNov 08Option Exercise38.045,000190,20010,100Nov 09 03:52 PM
GLOCER THOMAS HDirectorNov 08Sale56.205,000280,9835,100Nov 09 03:52 PM